0B68 McCue, Peter A. - Thomas Jefferson University - Thomas Jefferson University

Peter A. McCue, MD

Contact Dr. McCue

132 S. 10th Street
Main Building, Suite 285
Philadelphia, PA 19107

(215) 955-5588

Most Recent Peer-reviewed Publications

  1. Sox10 - A marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: A systematic analysis of 5134 tumors
  2. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  3. A systematic immunohistochemical study of 3215 cases
  4. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth
  5. GATA3: A multispecific but potentially useful marker in surgical pathology: A systematic analysis of 2500 epithelial and nonepithelial tumors
  6. Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms
  7. Predictors of positive surgical margins after radical prostatectomy at a single institution: Preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location
  8. Targeting cell cycle and hormone receptor pathways in cancer
  9. Pharmacologic inhibition of Jak2-Stat5 signaling by Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer
  10. Sarcoidosis mimicking metastatic bone disease in head and neck cancer
  11. STAT5A/B gene locus undergoes amplification during human prostate cancer progression
  12. Molecular diagnosis of prostate cancer: Are we up to age?
  13. Aberrant BAF57 signaling facilitates prometastatic phenotypes
  14. Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures
  15. Dual roles of PARP-1 promote cancer growth and progression
  16. Knockdown of Ki-67 by Dicer-Substrate Small Interfering RNA Sensitizes Bladder Cancer Cells to Curcumin-Induced Tumor Inhibition
  17. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: A randomized, double-blind trial of dutasteride pretreatment
  18. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis
  19. Renal medullary carcinomas: Histopathologic phenotype associated with diverse genotypes
  20. Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells